Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors

NCT02412423 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation

Interventions

DRUG: post-transplantation cyclophosphamide

Sponsor

Peking University People's Hospital